Accuracy of a Text Intervention to Minimize the Burden of Cancer Care Among Patients Treated With Immune Checkpoint Inhibitors

Erin M Bange; Kerry Coughlin; Wenrui Li; Elizabeth Moriarty; Timothy J Brown; Lawrence N Shulman; Ronac Mamtani

doi:10.1001/jamanetworkopen.2022.28452

Accuracy of a Text Intervention to Minimize the Burden of Cancer Care Among Patients Treated With Immune Checkpoint Inhibitors

JAMA Netw Open. 2022 Aug 1;5(8):e2228452. doi: 10.1001/jamanetworkopen.2022.28452.

Authors

Erin M Bange^{1

2}, Kerry Coughlin², Wenrui Li³, Elizabeth Moriarty^{1

2}, Timothy J Brown^{1

2}, Lawrence N Shulman^{1

2}, Ronac Mamtani^{1

2

3}

Affiliations

¹ Abramson Cancer Center, University of Pennsylvania, Philadelphia.
² Penn Center for Cancer Care Innovation, University of Pennsylvania, Philadelphia.
³ Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia.

Abstract

This cross-sectional study examines whether patients with cancer without symptoms of immune checkpoint inhibitor toxic effects can be accurately identified using a text message–based triage instrument and safely proceed to treatment.

Publication types

Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural

MeSH terms

Antineoplastic Agents, Immunological* / therapeutic use
Humans
Immune Checkpoint Inhibitors
Immunotherapy
Neoplasms* / therapy

Substances

Antineoplastic Agents, Immunological
Immune Checkpoint Inhibitors

Grants and funding

T32 CA009679/CA/NCI NIH HHS/United States